Rhoen Klinikum (ETR:RHK) Stock Price Down 0.2%

Rhoen Klinikum AG (ETR:RHK)’s share price was down 0.2% during mid-day trading on Tuesday . The company traded as low as €18.08 ($20.31) and last traded at €18.16 ($20.40), approximately 50,219 shares changed hands during mid-day trading. An increase of 16% from the average daily volume of 43,281 shares. The stock had previously closed at €18.20 ($20.45).

A number of equities research analysts have recently issued reports on RHK shares. Kepler Capital Markets set a €18.00 ($20.22) target price on shares of Rhoen Klinikum and gave the company a “neutral” rating in a research report on Monday, March 2nd. Independent Research set a €18.00 ($20.22) price objective on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Monday, June 8th. Finally, Berenberg Bank set a €18.00 ($20.22) price objective on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Tuesday, March 3rd.

The company’s 50-day moving average is €18.18 and its two-hundred day moving average is €17.63. The company has a debt-to-equity ratio of 14.58, a current ratio of 2.11 and a quick ratio of 1.96. The firm has a market cap of $1.22 billion and a P/E ratio of 30.27.

About Rhoen Klinikum (ETR:RHK)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Article: Risk Tolerance

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.